Sopharma AD (BUL: SFA)
Health Care · Pharmaceuticals · BG
€2.62
-0.38% today · -3.0% 1Y
Sopharma AD (BUL: SFA) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $1.58B.
Over the last twelve months the share price has lost 3.0%, trading between 1.34 and 2.64.
Tweenvest scores Sopharma AD across four factors: quality 70/100, value 19/100, growth 86/100, dividend 60/100. Its strongest factor is growth.
SFA price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.58B
- Revenue (TTM)
- $1.66B
- P/E
- 11.51
- EPS
- 0.23
- Dividend yield
- 2.87%
- Beta (5Y)
- 0.14
- 52-week high
- €2.64
- 52-week low
- €1.34
- Avg volume (3M)
- —
- Shares outstanding
- 538.41M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Inner Mongolia Furui Medical Science Co., Ltd.SZSE: 300049 | $1.60B | CN¥40.49 | -14.05% |
| Consun Pharmaceutical Group LimitedSEHK: 1681 | $1.59B | HK$14.85 | +0.81% |
| ANI Pharmaceuticals, Inc.NasdaqGM: ANIP | $1.58B | $73.89 | 0.00% |
| CSPC Hunan Jingfeng Pharmaceutical Co., Ltd.SZSE: 000908 | $1.58B | CN¥6.02 | +0.50% |
| Eton Pharmaceuticals, Inc.NasdaqGM: ETON | $1.58B | $55.76 | +1.00% |
| Mezzion Pharma Co.,Ltd.KOSDAQ: A140410 | $1.57B | ₩69,000.00 | +1.47% |
| Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd.SZSE: 300357 | $1.56B | CN¥19.99 | -1.67% |
| Square Pharmaceuticals PLC.DSE: SQURPHARMA | $1.56B | Tk217.10 | -0.55% |
Figures last refreshed Oct 11, 2026.